Daré Bioscience, Inc. (NASDAQ:DARE) Q1 2023 Earnings Call Transcript

Operator: Welcome to the conference call hosted by Daré Bioscience to review the Company’s Financial Results for the Quarter Ended March 31, 2023, and to provide a General Business Update.

Related Keywords

United States ,United Kingdom ,Australia ,British ,Doug Tsao ,Catherine Novack ,Kumar Raja ,Kemp Dolliver ,Sabrina Martucci Johnson ,Lisa Walters Hoffert ,Nasdaq ,Academy Of Managed Care Pharmacy ,Jones Research ,American College Of Obstetricians ,Company Financial Results For The Quarter Ended ,Dare Bioscience Inc ,Bioscience Inc ,Pfizer ,Marquee Conference In Women Health ,Call Transcript May ,Financial Results ,Quarter Ended March ,General Business ,Chief Executive Officer ,John Fair ,Chief Commercial Officer ,Chief Financial ,Martucci Johnson ,Private Securities Litigation Reform Act ,Sildenafil Cream ,British Medical Journal ,Managed Care ,Marquee Conference ,American College ,Annual Clinical ,Scientific Meeting ,Dare Bioscience ,Brookline Capital ,